Skip to content
Recall Observatory FDA recall evidence

Drug product

Viorele, Desogestrel and Ethinyl Estradiol, USP, 0.15 mg/ 0.02 mg and Ethinyl Estradiol Tablets, USP, 0.01 mg, 3 Blisters each containing 28 Tablets, Rx only, 28 day Regimen, Manufactured by: Glenmark Pharmaceuticals Limited, Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA., Mahwah, NJ, 07430, NDC 68462-318-29.

D-0021-2026

September 03, 2025

Class II

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 97547
Status
Ongoing
Classification
Class II
Quantity
26,928 packs
Official record key
drug-enforcement:D-0021-2026

Official wording

Reason: Failed Impurities/Degradation Specifications

Code information: Batch number 20230733, Exp Date: October 2025

Distribution pattern: US Nationwide.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications